.Pharmacolibrary.Drugs.M_MusculoSkeletalSystem.M01A_AntiinflammatoryAndAntirheumaticProductsNonStero.M01AH02_Rofecoxib.Rofecoxib .Pharmacolibrary.Drugs.M_MusculoSkeletalSystem.M01A_AntiinflammatoryAndAntirheumaticProductsNonStero.M01AH02_Rofecoxib.Rofecoxib| name: | Rofecoxib |
| ATC code: | M01AH02 | route: | oral |
| n-compartments | 1 |
Rofecoxib is a nonsteroidal anti-inflammatory drug (NSAID) of the selective COX-2 inhibitor class, previously marketed for the treatment of osteoarthritis, acute pain conditions, and dysmenorrhea. Its use has been discontinued worldwide due to concerns over increased risk of cardiovascular events.
Pharmacokinetic parameters reported in healthy adult volunteers following single oral administration.
Huntjens, DR, et al., & Della Pasqua, O (2008). Population pharmacokinetic modelling of the enterohepatic recirculation of diclofenac and rofecoxib in rats. British journal of pharmacology 153(5) 1072–1084. DOI:10.1038/sj.bjp.0707643 PUBMED:https://pubmed.ncbi.nlm.nih.gov/18193075
Burian, M, & Geisslinger, G (2003). [Clinical pharmacology of the selective COX-2 inhibitors]. Der Orthopade 32(12) 1078–1087. DOI:10.1007/s00132-003-0569-0 PUBMED:https://pubmed.ncbi.nlm.nih.gov/14655004